|
|
 |
||
 |
 |
 |
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
| Division of Haematology | |
| Head of Division: Professor Gregory Cheng | |
| Members: | |
| Dr. Raymond Wong | |
| Research Interests: | |
| Transfusion medicine, auto immune haematological disease, leukemia, stem cell transplantation. | |
| Selected Publications: | |
| 1. | Cheng, G., D.S.M. Chiu, and A.S.M. Chung, et al. "A Novel System for Providing Compatible Blood to Patients during Surgery -'Self-service' Electronic Blood Banking by Nursing staff." Transfusion 36 (1996): 347-350. |
| 2. | Lau, C. P., H. F. Tse, and G. Cheng. "Effects of Atrioventricular Asynchrony on Platelet activation : Implication of Thromboembolism in Paced Patients." Heart 78 (1997): 358-363. |
| 3. | 3. Wong, R., F. Y. Lau, C. H. Chui, K. S. Tsang, K. W. Chik, C.K. Li, and G. Cheng. "Transfusion of Peripheral Blood Stem Cells from Donor Homozygous for a Shared HLA-haplotype - Avoiding Fatal Transfusion Associated Graft-versus-host Disease while Preserving Anti-leukaemic Effect." Transplantation 71 (2001): 487-90. |
| 4. | Lau F. Y., R. Wong, N. P. H. Chan, H. C. Chui, E. Ng, M. H. L. Ng, G. Cheng. "Provision of phenotype-matched blood units: no need for pre-transfusion antibody screening." Haematologica 86 (2001):742-748. |
| 5. | Yunfeng Cheng, Raymond S.M. Wong, Yannie O.Y. Soo, Chung Hin Chui, Fung Yi Lau, Natalie P.H. Chan, Wai Shan Wong, Gregory Cheng. Initial Treatment of Immune Thrombocytopenic Purpura with High-Dose Dexamethasone. NEJM 2003 Aug; 349:831-836. |
| 6. | Raymond S.M. Wong, Alan K.L. Wu, K.F. To, Nelson Lee, Christopher W.K. Lam, C.K. Wong, Paul K.S. Chan, Margaret H.L. Ng, L.M. Yu, David S Hui, John S Tam, Gregory Cheng and Joseph J.Y. Sung. Haematological Manifestations in Patients with Severe Acute Respiratory Syndrome Retrospective Analysis. BMJ 2003;326:1358-1362. |
| 7. | Y Soo, YF Cheng, R Wong, D Hui, CK Lee, K Tsang, M Ng, WS Wong, P Chan, G Cheng, J Sung. Retrospective Comparison of Convalescent plasma with Continuing High Dose Methylprednisolne Treatment in SARS patients. CMI 2004 Jul;10(7):676-8. |
| 8. | Joyce HS You, Fredric WH Chan, Raymond SM Wong, Gregory Cheng. The Potential Clinical and Economic Outcomes of Pharmacogenetics-oriented Management of Warfarin Therapy ·V A Decision Analysis. Thomb Haemost 2004 Sep;92(3):590-7. |
| 9. | Yunfeng Cheng, Raymond Wong, Yannie OY Soo, WS Wong, CK Lee, Margaret HL Ng, Paul Chan, KC Wong, CB Leung, Gregory Cheng. Use of Convalescent Plasma Therapy in SARS patients in Hong Kong. EUR J Clin. Microbiol Infect Dis. 2005 Jan;24(1):44-6. |
| 10. | Yunfeng Cheng, Gregory Cheng, CH Chui, FY Lau, Paul KS Chan, Margaret HL Ng, Aldo Wong, Bing L Wong, Joseph JY Sung, Raymond SM Wong. ABO Blood Group and Human Susceptibility to SARS. JAMA Vol. 293, no. 12:1450-51, Mar 05. |
| 11. | Joyce H.S., Fredric W.H. Chan, Raymond S.M. Wong, Gregory Cheng. Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation? Br. J Clin Phormacol. 59:5;582-587, May 05. |
| 12. | 12. Chui CH, Lau FY, Tang JC, Kan KL, Cheng GYM, Wong RS, Kok SH, Lai PB, Ho R, Gambari R, Chan AS. Activities of fresh juice of Scutellaria barbata and warmed water extract of Radix Sophorae Tonkinensis on anti-proliferation and apoptosis of human cancer cell lines. Int J Mol Med. 2005 Aug;16(2):337-41. |
| 13. | Chui CH, Gambari R, Lau FY, Teo ITN, Ho KP, Cheng GYM, Ke B, Higa T, Kok SHL, Chan ASC and Tang JCO; Anti-cancer potential of traditional Chinese herbal medicines and microbial fermentation products. Minerva Biotenologica 17:183-192,2005. |
